Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04286867 · ClinicalTrials.gov registry record · Phase 1
Examining Alcohol Consumption, Perceptions, and User Experience of Alcohol Moderation Strategies
A Phase 1 study of Alcohol Use Disorder and Alcohol Abuse, sponsored by Kent State University.
- Completed
- Registry status
- Phase 1
- Development phase
- 64
- Enrollment target
- 1
- Study location
NCT04286867: Completed Phase 1 study of Alcohol Use Disorder and Alcohol Abuse, sponsored by Kent State University.
NCT04286867 is a Phase 1 study of Alcohol Use Disorder and Alcohol Abuse that has completed, run by Kent State University. The registered enrollment target is 64 participants, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04286867, a Phase 1 study of Alcohol Use Disorder and Alcohol Abuse, has completed, sponsored by Kent State University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aims of the study are to assess the user experience and initial efficacy of a mobile application designed to reduce problematic alcohol use. The application utilizes drinking limits, defined by the user, to pace alcohol consumption during drinking occasions. The mobile application will be compared to strategies for tracking drinking detailed within the National Institute on Alcohol Abuse and Alcoholism Alcohol Moderation Strategies (https://www.rethinkingdrinking.niaaa.nih.gov/thinking-about-a-change/strategies-for-cutting-down/tips-to-try.aspx). Primary outcome variables, in addition to variables assessing user design experience of the application and use of moderation strategies, include (1) negative consequences of alcohol use during a 14 day observation period, and (2) number of drinks consumed per drinking day during a 14 day observation period.
Primary Outcome
The Brief Young Adult Alcohol Consequences Questionnaire (BYAACQ) will be used to assess negative consequences of alcohol use (24-items). Minimum score is 0, maximum is 24, with higher scores indicating more negative consequences of alcohol use.
Conditions Studied
Interventions
- OTHER Alcohol Moderation Mobile Application
- BEHAVIORAL Alcohol Moderation Drink Tracker
Study Locations (1)
Ohio
- Kent State University - Kent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2020-02-05 |
| Est. Completion | 2022-05-10 |
| Phase | Phase 1 |
What the finished NCT04286867 record still lists
NCT04286867 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (80% lower).
The record links to 3 conditions, with Alcohol Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Alcohol Moderation Mobile Application is the first listed.
NCT04286867 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04286867 about?
NCT04286867 is a clinical study titled "Examining Alcohol Consumption, Perceptions, and User Experience of Alcohol Moderation Strategies". The primary aims of the study are to assess the user experience and initial efficacy of a mobile application designed to reduce problematic alcohol use. The application utilizes drinking limits, defined by the user, to pace alcohol consumption during drinking occasions. The mobile application will b...
What is the current status of trial NCT04286867?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 64 participants. The study started on 2020-02-05. Estimated completion is 2022-05-10.
What conditions does trial NCT04286867 study?
This clinical trial studies the following conditions: Alcohol Use Disorder, Alcohol Abuse, Alcohol Abuse, Episodic.
What interventions are being tested in trial NCT04286867?
The interventions under investigation include: Alcohol Moderation Mobile Application (OTHER), Alcohol Moderation Drink Tracker (BEHAVIORAL).
Who is sponsoring clinical trial NCT04286867?
This trial is sponsored by Kent State University, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04286867 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04286867's enrollment target sits among peer trials
64 111th of 184 higher than 74 of 184 other Alcohol Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Intranasal Insulin for Treatment of Alcohol Use Disorder
RECRUITING · Phase 1
-
Acute Effects of Alcohol on PET Imaging of Phosphodiesterase-4B (PDE4B)
RECRUITING · Phase 1
-
Environment and Alcohol: A Pilot Study
RECRUITING · Phase 1
-
PET Imaging of Phosphodiesterase-4B (PDE4B) in Alcohol Use Disorder
RECRUITING · Phase 1
-
Sex Differences in the Response to Abstinence From Alcohol.
RECRUITING · Phase 1
-
PT150 Drug for Use in Alcohol Use Disorder
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI